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Summary
This paper presents several methods and instruments
developed for the characterization of enzymatic mem
branes and enzyme electrodes:
1. amplitude and response time of steady-state and
transient responses to glueose, automatically deter¬
mined with an Apple II based workstation,
2. enzyme electrode response to in vitro simulated
I.V.G.T.T. and to in vivo I.V.G.T.T. when connected
to an extracorporal blood shunt of conscious rats.
Key-Words: Biosensor, Glucose Electrode, GOD
Membrane, Blood Shunt, I. V. G. T. T.
Introduction
Among specific electrodes, enzyme-based sensors are
probably the most specific and versatile but their
operating behaviour is very complex (Thévenot 1985)
Their ability to monitor metabolites and especially
glueose concentration has been demonstrated since
the pioneer work of Clark and Lyons ( 1962). The
major interest and possibilities of such biosensors for
*Present address: Dr. med. T. Tallagrand, O.C.T.E.T., 5 rue
Etienne d'Orves, 94000 Creteil, France.
Presented during the International Workshop "Implantable
Glucose Sensors - State of the Art", Schloft Reisenburg,
Ulm, G.F.R. (January 4-6, 1987).
in vivo implants (Turner and Pickup 1985; Velho,
Reach and Thévenot 1987) have led several groups to
spent time and efforts for a better understanding of
their operating properties. This paper presents briefly
our recent strategies for in vitro and in vivo evaluation
of glueose sensors using glucose oxidase (GOD) mem¬
branes and anodic detection of enzymatically gen¬
erated hydrogen peroxide.
WAR electrodes
enzymatic
membrane
spacer
Fig. 1 Schematic of electrochemical glucose sensor using
modified LC-EC detector.
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Table 1 Main analytical parameters of 3 different types of GOD membranes and related glucose sensors used in extracorporal
blood shunts.
Parameters Membrane Type 1 Type 2 Type 3
Membrane material reconstituted
collagen
collagen +
cellulose acetate
cellulose
acetate
Immobilization procedure acyl azide
activation
acyl azide
activation
entrapment
Membrane thickness
(micro, m)
dry: 100
swollen: 200—400
100+ 15
300 + 15
5-25
5-25
Glucose responses:
— sensitivity"*"
(micro. A.M.-1.mm-2) 90 0.7 0.5-2.0
— linear range (mM)
lower range
upper range
0.0001
2-3
0.1
40
0.1
10-30
— response time
transient (sec)
steady-state (min)
20-50
2-4
50-90
3-6
10-60
0.5-3
— stability (days)* 120-2000 4-8
+all sensor responses are referred to anode area.
*stabilities are evaluated for a 50% decrease of sensitivity, either (lower value) under operation or (higher values) in storage
conditions.
Material and Methods
1. Enzyme electrodes
All enzyme electrodes used in this study consist of
glucose oxidase (GOD) membranes maintained in
close contact with a platinum disk of a modified
LC-EC detector (Solea Tacussel type DEL-1) (Fig. 1).
Enzymatic membranes are either prepared by acyl-
azide activation of reconstituted collagen films (Thé¬
venot, Sternberg, Coulet, Laurent and Gautheron
1979) or by entrapment of enzyme in cellulose ace¬
tate films (Sternberg, Tallagrand and Thévenot 1983).
Solution is circulated to the cell using a Gilson Mini-
plus II peristaltic pump at a flow rate ranging between
0.1 and 2 ml/min.
2. Analytical evaluation of sensors
All assays were performed by step increase or decrease
of glucose concentration within the 2.5—20 mM range.
Responses are calculated either by comparing steady-
state current to background current Ibg prior to any
glucose addition or by substracting the steady-state
current corresponding to previous addition: thus
either I — Ibg vs C or delta.l/delta.C vs Cor log C
curves are plotted.
3. Biological evaluation of sensor
The sensor was connected to the extracorporal blood
loop of a conscious rat using a jugular vein and a
carotid artery. Total volume of the shunt was about
1.5 ml. Sensor output current was recorded during
successive hyperglycemic tests stimulated by venous
injection (0.5 g/kg) and blood glucose levels were
simultaneously detennined using a Beckman Glucose
Analyser.
Analytical Evaluation of the Glucose Sensor
A modified LC-EC cell was used to evaluate GOD
membrane properties: the membrane was placed in
the cell between the sensing electrodes and the teflon
spacer (Fig. 1). Enzymatically generated hydrogen
peroxide was immediately detected by anodic ampero-
metry on platinum disk. For routine operations an
Apple 11+ or He based workstation was used both to
control glucose standard addition with an electronic
buret, to record sensor output signal and to determine
automatically steady-state and transient responses and
response times (Thévenot, Tallagrand and Sternberg
1987).
GOD membranes were submitted to a simulated
I.V.G.T.T. by varying input glucose concentration
levels between 2.5 and 20 mM and then, by steps,
between 20 and 5 mM. Such experiences lasted for
several hours and sensor stability, reproducibility
and response times were estimated in conditions sim¬
ilar to extracorporal blood shunt assays. As GOD col¬
lagen membranes presented too low values of linear
range (Table 1), they were covered with a thin non-
enzymatic CA membrane: these superposed mem¬
branes presented usually too large response times
and gave poor mechanical stability at 37°C. Thus
entrapped-GOD CA membranes were preferred for
in vivo assays.
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Biological Evaluation of the Glucose Sensor
Prior to any in vivo assays of flow-through glucose
sensors, GOD membranes were tested at 37°C and
pH 7.4 and selected for:
— a linear range of caJibration curves reaching at
least 15 mM,
— a steady state response time lower than 3—4 min,
-2
— a sensitivity reaching 1 microA. M"1 • mm
— a good membrane semipcrmeability, yielding
responses at least 10 times larger for small neutral
molecules, such as hydrogen peroxide, than for
small anions, such as ascorbate.
Using GOD membranes which gave acceptable para¬
meters with these flow-through sensors, we performed
in vivo I.V.G.T.T. on conscious rats. The response
characteristics of the glucose sensor was first eval¬
uated in vitro, i.e. in circulating buffer where the
levels of glucose are augmented in steps. Then the
sensor was connected to a rat through catheters
placed into a jugular vein and a carotid artery. The
concentration of glucose in the blood was changed
by intravenous injection of glucose into the catheter.
After such in vivo measurements, the loop was rinsed
and a second in vitro calibration was made. As fre¬
quent blood samples were detennined with a Beck-
man Glucose Analyser, it was possible to correlate
sensor output current to blood glycemia (Fig. 2).
Entrapped-GOD CA membranes demonstrated a
good in vivo linearity if the highest glucose values,
i.e. just after glucose injection, were skipped:
I (nA) = 2.22+0.331 (Glucose, mM) r2=0.954
(Fig. 2).
Using an in vivo calibration with initial blood glyce¬
mia, glucose concentrations determined by sensor
were well correlated with Beckman reference values.
These experiments show that the sensor response
time is too large to follow the very rapid blood glu¬
cose increase after venous injection but that their
operating behaviour is satisfactory. Furthermore, as
post-calibration curves were significantly lower than
pre-calibration ones, their slope decreasing of 50 to
80% for glucose and 30 to 75% for hydrogen peroxide
responses respectively, a partial membrane and/or
anode inactivation is probably occurring when un¬
diluted blood is in direct contact with the sensor's
enzyme membrane. Similar but more limited sensor
inactivation (5—20%) had been found previously
with GOD-collagen membranes and diluted whole
blood: such inhibition was totally reversible, initial
sensor sensitivity being reached after rinsing with
buffer solution (Sternberg, Apoteker and Thévenot
1980).
Conclusion
This presentation of evaluation procedures for glucose
sensors based on GOD membranes show the import-
I.V.G.T.T. on conscious rat
Variations of sensor output signal and blood glycemia
8 □ I/Io
x G/Go
Time ( min )
Blood Glycemia (mM)
Fig. 2 Biological evaluation of the glucose sensor with extra¬
corporal blood shunt on a conscious free moving rat, during
I.V.G.T.T.: (upper curves) relative variations of sensor out¬
put current and blood glycemia, and (lower curve) correla¬
tion of in vivo glucose sensor current and reference values,
using a Beckman Glucometer.
ance of a systematic detemiination of several analy¬
tical parameters and demonstrates the interest of a
versatile cell assembly and workstation to perform
such routine assays.
Entrapped-GOD CA membranes may be easily pre¬
pared by film casting, but their enzyme activity and
stability is probably too limited for the development
of implanted glucose sensor (Table 1): higher surface
activity and more stable covalent GOD coupling
seem necessary. An outer membrane or layer seems
also necessary both to limit any GOD leakage into
blood or body fluid, and to restrict diffusion of
glucose thus increasing the upper limit of the sensor
linear range (Mullen, Keedy, Churehouse and Vadgama
1986). Although they are difficult to calibrate directly
and may give some physiologically inherent time lag,
subcutaneous sensors seem preferable to venous ones;
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since the original work of Shichiri and Kawamori
(1983) several research groups have worked on
needle-type microsenscrs and tested several fabrica¬
tion procedures (Millier, Abel and Fischer 1986).
Thus a change of strategy has been introduced within
our research group. New multilayer membranes are
developped using GOD either covalently coupled or
copolymerized on CA membranes: they present much
higher GOD activities and stabilities (Velho, Reach
and Thévenot 1986; Thévenot, Sternberg, Bindra and
Wilson 1987) and they can be adapted to the fabri¬
cation of needle-type glucose microsensors.
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